Sign in to fuzzto save your conversations, follow your research and come back anytime.

In the news

Sheela Foam Q1 FY27 PAT surges 839% to ₹61.4 crore

Sheela Foam shares surge 19% on record Q4 profit of ₹92 crore

Sheela Foam Surges 16.74% in Gap-Up Move, Sai Life Sciences Shows Mixed Performance

Sheela Foam surges 17.7% on 601% Q4 PAT jump to ₹912 crore

Sheela Foam surges 20% on Q4 PAT jump to ₹91 cr

Sheela Foam surges 20% on strong Q4 results, ₹91.28 cr profit

Sheela Foam shares surge 20% on strong Q3 results, Kurlon acquisition delivers
The Quarter story
The two most recent quarterly results, compared side-by-side.
Sheela Foam scales distribution and trims costs, but faces margin pressure and volume contraction in core foam segments.
Dealer network expanded from 84 in Q1 FY26 to 9,900 in Q1 FY27, confirming aggressive distribution scaling.
Total foam volume fell from 24,262 MT in Q2 FY26 to 11,764 MT in Q1 FY27, signaling demand weakness.
Finance cost declined from ₹29 Cr in Q1 FY26 to ₹12 Cr in Q1 FY27, reflecting steady debt reduction.
Consolidated EBITDA margin slipped from 11.5% in Q4 FY26 to 9.0% in Q1 FY27, highlighting cost pressure.
Australia gross margin expanded from 53.6% in Q3 FY26 to 59.2% in Q1 FY27, confirming pricing strength.
Standalone gross margin dropped from 43.9% in Q2 FY26 to 37.6% in Q1 FY27, indicating margin compression.
STAQO revenue grew from ₹16 Cr in Q2 FY26 to ₹24 Cr in Q1 FY27, showing consistent top-line expansion.
Headcount fell from 231 in Q3 FY26 to 90 in Q1 FY27, reflecting workforce restructuring.
Operating expenses declined from ₹958 Cr in Q3 FY26 to ₹693 Cr in Q1 FY27, showing cost discipline.
Other segment revenue declined from ₹48 Cr in Q2 FY26 to ₹27 Cr in Q1 FY27, indicating segment contraction.